These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26486326)

  • 1. Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.
    Cavalloni G; Peraldo-Neia C; Varamo C; Casorzo L; Dell'Aglio C; Bernabei P; Chiorino G; Aglietta M; Leone F
    Tumour Biol; 2016 Mar; 37(3):4041-52. PubMed ID: 26486326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation.
    Cavalloni G; Peraldo-Neia C; Sassi F; Chiorino G; Sarotto I; Aglietta M; Leone F
    BMC Cancer; 2016 Feb; 16():90. PubMed ID: 26868125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines.
    Zhang Y; Luo J; Dong X; Yang F; Zhang M; Zhao J; Wang Q; Zhou F; Sun J; Yang X
    Ann Surg Oncol; 2019 Nov; 26(12):4134-4147. PubMed ID: 31359275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand.
    Saensa-Ard S; Leuangwattanawanit S; Senggunprai L; Namwat N; Kongpetch S; Chamgramol Y; Loilome W; Khansaard W; Jusakul A; Prawan A; Pairojkul C; Khantikeo N; Yongvanit P; Kukongviriyapan V
    Tumour Biol; 2017 Nov; 39(11):1010428317725925. PubMed ID: 29110582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of a human cholangiocarcinoma cell line.
    Ma S; Hu L; Huang XH; Cao LQ; Chan KW; Wang Q; Guan XY
    Oncol Rep; 2007 Nov; 18(5):1195-200. PubMed ID: 17914572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
    Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
    Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
    Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report on establishment and characterization of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2.
    Jiang NZ; Bai MZ; Huang CF; Ma ZL; Zhong RY; Fu WK; Gao L; Tian L; Mi NN; Ma HD; Lu YW; Zhang ZA; Zhao JY; Yu HY; Zhang BP; Zhang XZ; Ren YX; Zhang C; Zhang Y; Yue P; Lin YY; Meng WB
    World J Gastroenterol; 2023 Nov; 29(41):5683-5698. PubMed ID: 38077157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma.
    Wang J; Zhang K; Wang J; Wu X; Liu X; Li B; Zhu Y; Yu Y; Cheng Q; Hu Z; Guo C; Hu S; Mu B; Tsai CH; Li J; Smith L; Yang L; Liu Q; Chu P; Chang V; Zhang B; Wu M; Jiang X; Yen Y
    Oncotarget; 2015 Aug; 6(22):18905-20. PubMed ID: 26056085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
    Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient.
    Peraldo-Neia C; Massa A; Vita F; Basiricò M; Raggi C; Bernabei P; Ostano P; Casorzo L; Panero M; Leone F; Cavalloni G; Aglietta M
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line.
    Peraldo Neia C; Cavalloni G; Chiorino G; Ostano P; Aglietta M; Leone F
    Oncotarget; 2016 Dec; 7(52):86766-86780. PubMed ID: 27902465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient.
    Rattanasinganchan P; Leelawat K; Treepongkaruna SA; Tocharoentanaphol C; Subwongcharoen S; Suthiphongchai T; Tohtong R
    World J Gastroenterol; 2006 Oct; 12(40):6500-6. PubMed ID: 17072981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between KRAS gene mutations and linicopathological features of patients with intrahepatic cholangiocarcinoma.
    Wang J; Xu MX; Wang LQ; Li HY; Wang ZL; Li LJ
    J Biol Regul Homeost Agents; 2019; 33(5):1551-1557. PubMed ID: 31635679
    [No Abstract]   [Full Text] [Related]  

  • 15. Difference in biological characteristics and sensitivity to chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro.
    He XR; Wu XP
    Chin Med Sci J; 2008 Mar; 23(1):54-9. PubMed ID: 18437912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
    Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
    Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line, ICC-X3.
    Xu H; Luo W; Zhao Z; Miao X; Chai C; Hu J; Tang H; Zhang H; Zhou W
    Hum Cell; 2023 Mar; 36(2):854-865. PubMed ID: 36662372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain.
    Wu CP; Zhou L; Gong HL; Du HD; Tian J; Sun S; Li JY
    Cancer Lett; 2014 Jan; 342(1):92-103. PubMed ID: 24001612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.
    Graham RP; Barr Fritcher EG; Pestova E; Schulz J; Sitailo LA; Vasmatzis G; Murphy SJ; McWilliams RR; Hart SN; Halling KC; Roberts LR; Gores GJ; Couch FJ; Zhang L; Borad MJ; Kipp BR
    Hum Pathol; 2014 Aug; 45(8):1630-8. PubMed ID: 24837095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.
    Huang WT; Weng SW; Wei YC; You HL; Wang JT; Eng HL
    Int J Clin Exp Pathol; 2014; 7(10):6841-51. PubMed ID: 25400767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.